Stepan (NYSE:SCL) Announces Quarterly Earnings Results, Beats Estimates By $0.06 EPS

Stepan (NYSE:SCL) issued its earnings results on Wednesday. The basic materials company reported $1.20 EPS for the quarter, topping the consensus estimate of $1.14 by $0.06, Briefing.com reports. The firm had revenue of $451.60 million during the quarter, compared to analysts’ expectations of $489.40 million. Stepan had a return on equity of 14.19% and a net margin of 5.39%. Stepan’s quarterly revenue was down 11.1% compared to the same quarter last year. During the same period last year, the business earned $1.11 earnings per share.

SCL traded down $1.16 during midday trading on Thursday, reaching $94.52. 1,135 shares of the company were exchanged, compared to its average volume of 67,057. The company has a debt-to-equity ratio of 0.28, a quick ratio of 1.97 and a current ratio of 2.69. Stepan has a one year low of $69.17 and a one year high of $101.84. The stock has a market capitalization of $2.14 billion, a P/E ratio of 19.55 and a beta of 1.28. The stock’s 50-day simple moving average is $95.98 and its 200 day simple moving average is $92.51.

SCL has been the subject of several research reports. Royal Bank of Canada began coverage on Stepan in a research report on Wednesday, July 3rd. They issued a “sector perform” rating and a $21.00 target price for the company. Scotiabank lowered Stepan to a “sector underperform” rating and set a $20.00 price objective for the company. in a research note on Tuesday, August 13th. ValuEngine lowered Stepan from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Zacks Investment Research lowered Stepan from a “buy” rating to a “hold” rating in a research note on Thursday, October 17th. Finally, BMO Capital Markets lowered their target price on Stepan from $28.00 to $20.00 and set an “outperform” rating for the company in a research note on Friday, August 9th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and two have assigned a buy rating to the company. The company currently has an average rating of “Hold” and an average target price of $54.71.

In other news, VP Frank Pacholec sold 2,383 shares of Stepan stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $97.23, for a total transaction of $231,699.09. Following the transaction, the vice president now owns 34,726 shares in the company, valued at approximately $3,376,408.98. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Sean Thomas Moriarty sold 1,092 shares of Stepan stock in a transaction dated Friday, August 9th. The shares were sold at an average price of $95.11, for a total value of $103,860.12. Following the transaction, the vice president now owns 5,075 shares in the company, valued at approximately $482,683.25. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 21,180 shares of company stock worth $2,074,308. Company insiders own 11.40% of the company’s stock.

Stepan Company Profile

Stepan Company, together with its subsidiaries, produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products in North America, Europe, Latin America, and Asia. The company operates through three segments: Surfactants, Polymers, and Specialty Products.

Featured Story: Why is the Consumer Price Index (CPI) important?

Earnings History for Stepan (NYSE:SCL)

Receive News & Ratings for Stepan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stepan and related companies with MarketBeat.com's FREE daily email newsletter.